Backed by Google and other noted venture capital companies, San Diego-based Locana, Inc. launched with $55 million in a Series A financing round that will be used to expand the company’s pipeline of RNA-targeting gene therapy programs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,